AliveCor Receives $10,500,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62f6cc76-e210-4af5-9383-a9c62aa72422&Preview=1 -
Date
6/11/2012 -
Company Name
AliveCor -
Mailing Address
Undisclosed San Francisco, CA 94121 -
Company Description
AliveCor Inc. develops and sells a wireless heart monitoring ECG device for the Apple iPhone. -
Website
http://www.alivecor.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,500,000 -
Transaction Round
Series B -
Proceeds Purposes
AliveCor will use the funding to launch and commercialize its mobile ECG device, pending 510(k) marketing clearance by the Food and Drug Administration, in the human health and animal health markets. The funding also enables expansion for new mHealth applications and services for international markets. -
M&A Terms
-
Venture Investor
Burrill & Company -
Venture Investor
Khosla Ventures -
Venture Investor
Qualcomm
